Lunai Bioworks Profit Margin 2013-2026 | LNAI
Current and historical gross margin, operating margin and net profit margin for Lunai Bioworks (LNAI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Lunai Bioworks net profit margin as of March 31, 2026 is 0%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.011B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.130B | 42.04 |
| Tempus AI (TEM) | United States | $14.045B | 0.00 |
| 10x Genomics (TXG) | United States | $9.980B | 0.00 |
| Hinge Health (HNGE) | United States | $7.658B | 73.57 |
| Hims & Hers Health (HIMS) | United States | $6.530B | 0.00 |
| Doximity (DOCS) | United States | $4.654B | 28.69 |
| Heartflow (HTFL) | United States | $4.413B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.604B | 237.67 |
| Privia Health (PRVA) | United States | $2.536B | 94.52 |
| Clover Health Investments (CLOV) | United States | $2.369B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.220B | 33.82 |
| Schrodinger (SDGR) | United States | $2.142B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.098B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 20.93 |
| Azenta (AZTA) | United States | $1.456B | 79.14 |
| Enovis (ENOV) | United States | $1.040B | 5.39 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.687B | 0.00 |
| Phreesia (PHR) | United States | $0.623B | 33.47 |
| Fulgent Genetics (FLGT) | United States | $0.597B | 0.00 |
| Veradigm (MDRX) | United States | $0.575B | 0.00 |
| Claritev (CTEV) | United States | $0.522B | 0.00 |
| Carlsmed (CARL) | United States | $0.425B | 0.00 |
| Evolent Health (EVH) | United States | $0.417B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.400B | 0.00 |
| CapsoVision (CV) | United States | $0.335B | 0.00 |
| Standard BioTools (LAB) | United States | $0.302B | 0.00 |
| American Well (AMWL) | United States | $0.228B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.131B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 6.78 |
| Pulmonx (LUNG) | United States | $0.089B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.063B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| 111 (YI) | China | $0.032B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartSciences (HSCS) | United States | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.012B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |